by Kazeem Olalekan Clearly I am excitable. When I learnt of the new iphone and Android app from the nice folks at NICE, then you know what is coming. Hee Heee Heeeeeeeeeeeeeeeeeeeeee Haaaaaaaaaaaah! I’ll tell you why. I spent my top dollar about a year ago on
Read more →
by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately
Read more →
by Kazeem Olalekan MRPharmS The recent acquisition of 45% stake in Boots the Chemist by US Firm, Walgreen could be viewed as another good example of the special relationship between the US and the UK. It has been reported that the two companies have very little overlap.
Read more →
by Kazeem Olalekan MRPharmS The final report on the transfer of information about medicine when patients move between care setting has been published. It makes for an interesting read. The main recommendations are: The report quoted an audit conducted in 2010 across 50 acute trusts
Read more →
by Kazeem Olalekan The Royal Pharmaceutical Society of Great Britain has issued advice to pharmacist on how to deal with requests for emergency supplies of regular medicines. The doctors go on strike this Thursday (21st of June). The key advise are:
Read more →
by Kazeem Olalekan Following from the recently completed election onto the National Pharmacy Board in England, Wales and Scotland; bookapharmacist.com is happy to note that this is an election it is proud of. Everyone is a winner: elected or not. We are releasing a YouTube video of
Read more →
by Kazeem Olalekan The publication of the final report into the PIP debacle, by the NHS Medical Director, should signal the ‘silence of the pips’. The report is making it clear that: This report should at least silence the pips and bring reassurance to worried patients. The
Read more →
